Roche Acquires Exclusive Licence for Clinical Phase Cancer Vaccine
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 83 (Table of Contents)
Published: 7 May-2007
DOI: 10.3833/pdr.v2007.i83.348 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Transgene and Roche entered into license agreement for Transgene’s TG400 I, which is in phase 2 clinical trials for treating anti-HPV cancer vaccine...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018